Gsk (GSK) Current Deferred Tax Assets (2010 - 2012)

Gsk (GSK) has 3 years of Current Deferred Tax Assets data on file, last reported at $176.6 million in Q4 2012.

• For the quarter ending Q4 2012, Current Deferred Tax Assets fell 76.03% year-over-year to $176.6 million; the trailing twelve-month figure through Dec 2012 stood at $176.6 million (down 76.03% YoY), and the FY2012 full-year result was $174.3 million, down 76.82% from the prior year.
• Current Deferred Tax Assets was $176.6 million for Q4 2012 at Gsk, down from $737.1 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $1.4 billion in Q4 2010 to a low of $176.6 million in Q4 2012.
• A 3-year average of $761.7 million and a median of $737.1 million in 2011 frame the typical range for Current Deferred Tax Assets.
• Across the five-year window, Current Deferred Tax Assets plunged 46.25% in 2011 and slumped 76.03% in 2012, its largest moves.
• Gsk's Current Deferred Tax Assets stood at $1.4 billion in 2010, then plunged by 46.25% to $737.1 million in 2011, then sank by 76.03% to $176.6 million in 2012.
• Per Business Quant data, the three most recent Current Deferred Tax Assets figures were $176.6 million in Q4 2012, $737.1 million in Q4 2011, and $1.4 billion in Q4 2010.